• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Immunol . SARS-CoV-2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults

tetano

Editor, Senior Moderator
Eur J Immunol


. 2026 Jan;56(1):e70127.
doi: 10.1002/eji.70127. SARS-CoV-2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults

Lisan H Kuijper[SUP] 1 2 [/SUP], Laura Y L Kummer[SUP] 1 2 3 [/SUP], Laura Fernandez Blanco[SUP] 1 2 3 [/SUP], Karlijn van der Straten[SUP] 2 4 [/SUP], Mathieu A F Claireaux[SUP] 2 4 [/SUP], Amélie V Bos[SUP] 1 2 [/SUP], Miranda C Dieker-Meijer[SUP] 1 2 [/SUP], Tineke Jorritsma[SUP] 1 2 [/SUP], Mariël C Duurland[SUP] 1 2 [/SUP], Maurice Steenhuis[SUP] 1 2 [/SUP], Juan J Garcia Vallejo[SUP] 2 5 [/SUP], Koos P J van Dam[SUP] 3 [/SUP], Eileen W Stalman[SUP] 3 [/SUP], Luuk Wieske[SUP] 3 6 [/SUP], Sander W Tas[SUP] 2 7 [/SUP], Laura Boekel[SUP] 2 8 [/SUP], Gert-Jan Wolbink[SUP] 2 8 [/SUP], Theo Rispens[SUP] 1 2 [/SUP], Taco W Kuijpers[SUP] 2 9 [/SUP], Filip Eftimov[SUP] 3 [/SUP], Marit J van Gils[SUP] 2 4 [/SUP], Anja Ten Brinke[SUP] 1 2 [/SUP], S Marieke van Ham[SUP] 1 2 10 [/SUP]; T2B! immunity against SARS‐CoV‐2 study group



Affiliations
Abstract

After antigen encounter, long-lived antibody-secreting cells (ASC) secrete high-affinity circulating antibodies. In addition, memory B cells (MBC) are quickly reactivated upon antigen re-exposure and predominantly generate shorter-lived ASCs. Studies have suggested that MBC can differentiate into ASCs without recognizing their cognate antigen, a process known as "bystander activation". This antigen-independent reactivation of MBC could help maintain circulating antibody levels, thereby protecting against future infections. To elucidate whether SARS-CoV-2 mRNA vaccination leads to bystander activation of B cells, the dynamics of antibody concentrations against six pathogen-specific antigens not encountered during the sampling period were analyzed over time. Deep profiling of antigen-specific B cell responses was simultaneously performed using multiparameter high-dimensional spectral flow cytometry. Antibody concentrations against tetanus toxoid (TT), respiratory syncytial virus (RSV), and influenza hemagglutinin (HA) unexpectedly increased 6 weeks after the first SARS-CoV-2 vaccination. Deep profiling of B cell differentiation stages demonstrated a short-term increase in influenza-specific IgG+ DN3 B cells, RSV-specific IgG+ CD11c+ activated B cells, and TT-specific IgG+ MBC following vaccination. In this study, we demonstrated at both the antibody and cellular levels that SARS-CoV-2 mRNA vaccination transiently activates distinct early activated B cell compartments directed against influenza HA, RSV, and TT.

Keywords: DN3; IgG+ activated B cells; antibodies; antibody‐secreting cells; memory B cells; noncognate antigen; serological memory.

 
Back
Top Bottom